NYMOX PHARMACEUTICAL CORPORATION (NYMXF) Net income 2015–2024
NYMOX PHARMACEUTICAL CORPORATION (NYMXF) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$4.5MFY2024 · since FY2015: -$17.9M → -$4.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | -$4.5M | +49.2% |
| FY2023 | -$8.8M | -34.5% |
| FY2022 | -$6.6M | +47.5% |
| FY2021 | -$12.5M | -6.8% |
| FY2020 | -$11.7M | +10.8% |
| FY2019 | -$13.2M | -24.2% |
| FY2018 | -$10.6M | +21.1% |
| FY2017 | -$13.4M | -2.4% |
| FY2016 | -$13.1M | +26.7% |
| FY2015 | -$17.9M | — |
Source: SEC XBRL filings · For reference only · Not investment advice